VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CTHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CTHRCharles & Colvard, Ltd.
$0.10$304032
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTHRFinancials

Charles & Colvard, Ltd. (CTHR) Financials

28Y historyFree accessUpdated daily

Revenue has contracted by 23.0% year-over-year to $4.0 million in 2025Q3, while gross margins have deteriorated to 23.0% from a 2023Q2 peak of 41.4%.

CTHR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'24Jun'23Jun'22Jun'21Jun'20Jun'19Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue15.75M21.96M29.95M43.09M39.24M29.19M32.24M27.03M29.17M30.77M25.64M28.49M22.41M16.03M12.69M8.31M14.73M27.82M40.71M43.54M23.92M17.24M16.51M11.51M12.8M12.3M4M100K100K
Revenue Growth %-33.51%-26.68%-30.5%9.82%34.42%-9.47%19.28%-7.32%-5.2%19.99%-9.99%27.1%39.79%26.38%52.62%-43.56%-47.06%-31.67%-6.5%82.06%38.73%4.4%43.53%-10.08%4.03%207.5%3900%0%-
Cost of Goods Sold13.1M16.76M25.21M22.85M20.81M21.2M17.35M15.47M20.4M20.55M18.01M14.6M9.96M6.51M4.83M3.47M5.59M7.61M10.8M14.46M8.57M6.58M6.59M5.14M5.26M5.7M2.7M00
COGS % of Revenue-76.35%84.19%53.02%53.04%72.63%53.82%57.23%69.94%66.8%70.25%51.25%44.44%40.61%38.04%41.78%37.98%27.35%26.52%33.22%35.83%38.14%39.89%44.66%41.1%46.34%67.5%--
Gross Profit2.64M5.19M4.73M20.24M18.43M7.99M14.89M11.56M8.77M10.21M7.63M13.89M12.45M9.52M7.86M4.84M9.13M20.21M29.92M29.08M15.35M10.66M9.93M6.37M7.54M6.6M1.3M100K100K
Gross Margin %16.78%23.65%15.81%46.98%46.96%27.37%46.18%42.77%30.06%33.2%29.75%48.75%55.56%59.39%61.96%58.22%62.02%72.65%73.48%66.78%64.17%61.86%60.11%55.34%58.9%53.66%32.5%100%100%
Gross Profit Growth %-9.69%-76.62%9.86%130.65%-46.35%28.8%31.89%-14.17%33.92%-45.08%11.51%30.77%21.14%62.43%-47.02%-54.8%-32.45%2.88%89.49%43.9%7.43%55.89%-15.51%14.19%407.69%1200%0%-
Operating Expenses14.63M19.8M18.71M17.37M12.92M14.3M12.63M12.17M12.59M19.76M16.66M15.37M12.22M8.22M6.62M8.05M16.03M19.88M20.49M19.95M12.31M8.57M7.38M5.47M14.73M12.8M9.9M5.4M400K
OpEx % of Revenue-90.17%62.48%40.31%32.92%49.01%39.16%45.02%43.15%64.24%64.98%53.95%54.51%51.29%52.17%96.89%108.88%71.48%50.32%45.82%51.46%49.71%44.66%47.53%115.12%104.07%247.5%5400%400%
Selling, General & Admin13.15M18.32M18.71M17.37M12.92M14.3M12.62M12.17M12.58M19.75M16.64M15.34M12.2M7.98M6.52M7.65M15.92M19.81M20.41M19.74M12.29M8.54M7.37M5.33M12.72M9.4M5.7M3.3M200K
SG&A % of Revenue-83.45%62.48%40.31%32.92%49.01%39.15%45.01%43.14%64.18%64.91%53.86%54.43%49.79%51.39%92.06%108.11%71.2%50.14%45.32%51.4%49.55%44.62%46.3%99.42%76.42%142.5%3300%200%
Research & Development0000002.07K3.71K2.85K17.8K18.07K24.9K17.01K145.72K99.89K401.5K113.62K76.65K73.23K215.78K14.08K26.7K7.26K21.98K1.44M2.7M4M2.1M200K
R&D % of Revenue------0.01%0.01%0.01%0.06%0.07%0.09%0.08%0.91%0.79%4.83%0.77%0.28%0.18%0.5%0.06%0.15%0.04%0.19%11.25%21.95%100%2100%200%
Other Operating Expenses1000K1.47M0000-1300000094.41K00000000-450119.46K569.99K700K200K00
Operating Income-11.98M-14.61M-13.98M2.87M5.51M-6.32M2.27M-608.54K-3.94M-9.55M-9.04M-1.58M234.06K1.3M1.24M-3.36M-6.9M325.45K9.43M9.13M3.04M2.09M2.55M899.14K-7.19M-6.2M-8.6M-5.3M-300K
Operating Margin %-76.1%-66.52%-46.67%6.67%14.04%-21.64%7.03%-2.25%-13.5%-31.04%-35.27%-5.55%1.04%8.1%9.79%-40.42%-46.85%1.17%23.16%20.97%12.7%12.15%15.45%7.82%-56.22%-50.41%-215%-5300%-300%
Operating Income Growth %--4.51%-586.43%-47.84%187.21%-378.77%472.29%84.54%58.78%-5.59%-472.32%-775.15%-81.99%4.63%136.96%51.31%-2220.25%-96.55%3.28%200.49%45.06%-17.91%183.77%112.5%-16.02%27.91%-62.26%-1666.67%-
EBITDA-11.6M-14.79M-13.32M3.35M6.08M-5.83M2.75M-186.53K-3.38M-8.69M-7.94M-717.6K842.23K1.6M1.38M-3.19M-6.68M526.07K9.62M9.38M3.24M2.26M2.68M1.05M-6.62M-5.5M-8.4M-4.9M-400K
EBITDA Margin %-73.63%-67.37%-44.49%7.78%15.48%-19.96%8.52%-0.69%-11.59%-28.23%-30.95%-2.52%3.76%9.97%10.86%-38.39%-45.39%1.89%23.62%21.54%13.53%13.09%16.23%9.13%-51.76%-44.72%-210%-4900%-400%
EBITDA Growth %35.22%-11.02%-497.4%-44.82%204.28%-312.08%1572.65%94.48%61.1%-9.46%-1005.94%-185.2%-47.32%16%143.2%52.26%-1370.6%-94.53%2.57%189.82%43.39%-15.81%155.23%115.85%-20.42%34.52%-71.43%-1125%-
D&A (Non-Cash Add-back)388.71K-185.28K653.16K479.31K567.12K490.24K481.32K422.02K557.39K863.35K1.11M862.68K608.16K299.55K136.62K168.88K216.03K200.63K188.76K247.44K197.19K161.9K128.6K150.94K569.99K700K200K400K-100K
EBIT-11.83M-14.42M-13.68M2.87M6.49M-6.16M2.28M-425.33K-3.94M-5.06M-9.04M-1.56M329.11K1.39M1.33M-3.54M-6.9M325.45K9.43M9.13M3.04M2.09M2.55M899.14K-7.19M-6.2M-8.6M-5.3M-300K
Net Interest Income16.16K243K297.26K19.28K-3.37K157.21K8.82K-541-1.74K-10.35K-83619.9K68.26K84.13K106.35K38.19K116.48K000000000000
Interest Income154.45K300.72K297.26K19.28K5.58K158.09K11.02K00116522.01K69.52K85.27K109.18K38.19K116.48K000000000000
Interest Expense138.3K57.72K008.95K8842.2K5411.74K10.36K9012.11K1.26K1.14K2.83K000000001.22M00000
Other Income/Expense16.16K243K297.26K19.24K970.35K155.38K8.47K182.68K-1.74K-10.22K-83619.9K68.26K84.85K80.82K38.19K116.48K491.14K741.16K503.76K138.22K112.36K199.08K325.6K114.54K1M1.8M500K-100K
Pretax Income-11.97M-14.36M-13.68M2.89M6.48M-6.16M2.27M-425.87K-3.94M-9.56M-9.05M-1.56M302.32K1.38M1.32M-3.32M-6.78M816.58K10.17M9.63M3.18M2.21M2.75M1.22M-7.08M-5.2M-6.7M-4.9M-400K
Pretax Margin %-76%-65.42%-45.68%6.71%16.51%-21.11%7.05%-1.58%-13.5%-31.07%-35.28%-5.48%1.35%8.63%10.43%-39.96%-46.06%2.94%24.98%22.12%13.28%12.8%16.66%10.65%-55.32%-42.28%-167.5%-4900%-400%
Income Tax005.9M518.53K-6.33M1.73K-1.44K27.61K13.48K12.82K4.05M-269.29K-4.15M-183.95K-234.28K77.71K-632.67K841.01K4.07M3.76M1.56M1.16M-6.66M0006.7M4.9M0
Effective Tax Rate %0%0%-43.15%17.93%-97.75%-0.03%-0.06%-6.48%-0.34%-0.13%-44.8%17.26%-1371.59%-13.29%-17.71%-2.34%9.33%102.99%39.97%39.02%49.24%52.72%-242.05%0%0%0%-100%-100%0%
Net Income-11.97M-14.36M-19.58M2.37M12.81M-6.16M2.28M-453.48K-4.53M-9.57M-13.1M-1.29M4.45M1.57M1.56M-3.4M-6.15M-24.42K6.11M5.87M1.61M1.04M9.41M1.22M-7.08M-5.2M-6.7M-4.9M-400K
Net Margin %-76%-65.42%-65.39%5.51%32.65%-21.11%7.06%-1.68%-15.52%-31.11%-51.08%-4.53%19.85%9.78%12.27%-40.89%-41.77%-0.09%15%13.49%6.74%6.05%56.97%10.65%-55.32%-42.28%-167.5%-4900%-400%
Net Income Growth %34.57%26.65%-924.83%-81.47%307.9%-370.81%601.78%89.98%52.72%26.91%-914.41%-129.02%183.71%0.72%145.8%44.74%-25084.77%-100.4%3.93%264.37%54.53%-88.91%668.2%117.3%-36.13%22.39%-36.73%-1125%-
Net Income (Continuing)-11.97M-14.36M-19.58M2.37M12.81M-6.16M2.28M-453.48K-3.95M-5.09M-13.1M-1.29M4.38M1.57M1.56M-3.4M-6.15M-24.42K6.11M5.87M1.61M1.04M9.41M1.22M-7.08M-5.2M-6.7M-4.9M-400K
Discontinued Operations00000000000000000000000000000
Minority Interest00000000000000000000000000000
EPS (Diluted)-3.84-4.73-6.450.764.20-2.201.00-0.39-1.90-2.50-6.50-0.650.220.080.08-0.18-0.34-0.000.330.310.090.060.530.08-0.75-0.56-0.73-1.31-0.07
EPS Growth %35.71%26.67%-948.68%-81.9%290.91%-320%356.41%79.47%24%61.54%-900%-395.45%175%0%144.44%47.06%--100.42%6.45%244.44%47.54%-88.49%595.54%110.16%-33.93%23.29%44.27%-1742.48%-
EPS (Basic)--4.73-6.450.784.40-2.151.04-0.36-1.89-2.49-1.15-0.110.230.080.08-0.18-0.34-0.000.340.330.090.060.530.08-0.75-0.56-0.73-1.31-0.07
Diluted Shares Outstanding3.12M3.03M3.04M3.13M3.02M2.86M2.21M2.13M2.09M2.04M2.03M1.99M19.97M19.7M19.42M18.72M18.24M18.07M18.66M18.96M18.01M17.78M17.91M16.48M9.41M9.24M9.13M3.74M5.63M
Basic Shares Outstanding3.12M3.03M3.04M3.04M3.05M2.8M2.28M1.95M2.38M3.83M11.42M11.42M19.58M19.44M19.18M18.72M18.24M18.07M18.16M18.01M17.47M17.36M17.53M16.47M9.41M9.24M9.13M3.74M5.63M
Dividend Payout Ratio------------------24.25%11.9%---------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and existential obsolescence

Sustained Revenue Contraction Trends

As reported in recent financial filings, CTHR has experienced a persistent double-digit revenue decline, with the most recent quarter showing a 23.0% year-over-year contraction to $4.0 million, signaling a fundamental erosion of the company's top-line relevance in the competitive bridge luxury jewelry market.

The consistent downward trajectory in revenue suggests that the company's core moissanite offering is losing market share to more competitively priced lab-grown diamond alternatives. Investors should monitor whether the pivot to the Caydia brand can stabilize top-line performance, though current data indicates that marketing efforts are failing to arrest the decline in consumer demand.

Structural Margin Compression and Volatility

According to the company's income statements, gross margins have deteriorated significantly, fluctuating from a peak of 41.4% in 2023Q2 to a recent 23.0% in 2025Q3, reflecting an inability to maintain pricing power amidst a commoditized synthetic gemstone landscape and aggressive inventory discounting.

The volatility in gross margins, punctuated by a negative 20.7% margin in 2024Q4, suggests that the company is highly susceptible to inventory write-downs and pricing pressure. This margin profile appears structurally weak, indicating that the brand lacks the premium positioning required to offset the rising costs of customer acquisition in a digital-first retail environment.

Operating Leverage Remains Deeply Negative

Based on the provided financial data, CTHR exhibits a severe lack of operating leverage, as evidenced by operating margins that have remained consistently negative, reaching -48.6% in 2025Q3, which implies that the current revenue scale is insufficient to cover the company's fixed corporate and marketing overhead.

The inability to scale operating income alongside revenue suggests that the company's cost structure is misaligned with its current market reality. Without a significant reduction in SG&A expenses or a dramatic recovery in sales volume, the company appears trapped in a cycle of operating losses that threatens its long-term viability.

Existential Risks to Business Model

Financial statements indicate that the company's reliance on a single, commoditized product category has left it vulnerable, with operating losses totaling millions per quarter and cash reserves dwindling, which may suggest that the current business model is approaching an unsustainable inflection point for shareholders.

Short-sellers would likely focus on the rapid depletion of cash relative to the persistent operating burn, which may necessitate dilutive financing in the near term. The fundamental risk remains that the company's core product, moissanite, may face total price parity with lab-grown diamonds, effectively eliminating the company's primary value proposition to the consumer.

CTHR — Frequently Asked Questions

Quick answers to the most common questions about buying CTHR stock.

What was Charles & Colvard, Ltd.'s (CTHR) revenue in 2024?

For fiscal year 2024, Charles & Colvard, Ltd. (CTHR) reported total revenue of $22.0M. This represents a 21856.5% increase compared to $0.1M in 1997.

Is Charles & Colvard, Ltd. (CTHR) profitable?

Charles & Colvard, Ltd. (CTHR) reported a net loss of $14.4M for the fiscal year ending 2024.

What is Charles & Colvard, Ltd.'s operating profit margin?

Charles & Colvard, Ltd. (CTHR) reported an operating income of $-14.6M, resulting in an operating profit margin of -66.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Charles & Colvard, Ltd.'s gross profit and gross margin?

Charles & Colvard, Ltd. (CTHR) generated $5.2M in gross profit for the year, representing a gross profit margin of 23.6%. This demonstrates the company's core pricing power and production efficiency.